Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)
China · Delayed Price · Currency is CNY 17.89
-0.11 (-0.61%)
Sep 8, 2025, 11:45 AM CST
SHE:000403 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2016 - 2020 |
Operating Revenue | 2,504 | 2,654 | 2,325 | 2,396 | 1,966 | 1,042 | Upgrade |
Other Revenue | 0.87 | 1.05 | 3.27 | 9.59 | 5.27 | 7.44 | Upgrade |
| 2,505 | 2,655 | 2,329 | 2,405 | 1,972 | 1,050 | Upgrade | |
Revenue Growth (YoY) | -9.10% | 14.00% | -3.18% | 21.98% | 87.80% | 14.67% | Upgrade |
Cost of Revenue | 1,309 | 1,352 | 1,130 | 1,151 | 1,064 | 537.36 | Upgrade |
Gross Profit | 1,196 | 1,303 | 1,199 | 1,254 | 907.93 | 512.58 | Upgrade |
Selling, General & Admin | 424.49 | 437.26 | 465.81 | 565.05 | 419 | 276.16 | Upgrade |
Research & Development | 40.34 | 55.18 | 79.69 | 75.36 | 35.63 | 11 | Upgrade |
Other Operating Expenses | 26.88 | 22.07 | 21.69 | 16.8 | 15.28 | 2.52 | Upgrade |
Operating Expenses | 487.7 | 509.9 | 565.15 | 666.86 | 477.73 | 285.99 | Upgrade |
Operating Income | 708.66 | 793.13 | 633.7 | 587.01 | 430.2 | 226.59 | Upgrade |
Interest Expense | -12.23 | -10.67 | -9.63 | -12.03 | -10.78 | -19.31 | Upgrade |
Interest & Investment Income | 64.15 | 78.01 | 75.08 | 68.22 | 62.3 | 18.31 | Upgrade |
Currency Exchange Gain (Loss) | 0.13 | 0.13 | -0.12 | 2.4 | -0.21 | - | Upgrade |
Other Non Operating Income (Expenses) | 11.74 | 0.03 | 0.64 | -2.23 | -3.44 | -3.67 | Upgrade |
EBT Excluding Unusual Items | 772.45 | 860.61 | 699.67 | 643.37 | 478.06 | 221.92 | Upgrade |
Impairment of Goodwill | - | - | - | - | -103.18 | - | Upgrade |
Gain (Loss) on Sale of Investments | 13.86 | 6.38 | -18.97 | 4.93 | 74.21 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -0.12 | -0.54 | 0.44 | 0.27 | 0.02 | Upgrade |
Asset Writedown | -3.77 | -3.46 | -1.29 | -3.59 | -0.49 | -5.27 | Upgrade |
Legal Settlements | -0.65 | - | - | - | -2.14 | - | Upgrade |
Other Unusual Items | -31.24 | -10.87 | 9.25 | 15.24 | 11.28 | 0.52 | Upgrade |
Pretax Income | 750.86 | 852.78 | 688.11 | 660.39 | 458.01 | 217.19 | Upgrade |
Income Tax Expense | 96.87 | 107.74 | 76.64 | 72.7 | 66.47 | 34.51 | Upgrade |
Earnings From Continuing Operations | 653.98 | 745.04 | 611.47 | 587.69 | 391.54 | 182.68 | Upgrade |
Minority Interest in Earnings | 0.15 | 0.28 | 0.64 | -0.56 | -0.48 | 3.28 | Upgrade |
Net Income | 654.13 | 745.32 | 612.11 | 587.13 | 391.06 | 185.97 | Upgrade |
Net Income to Common | 654.13 | 745.32 | 612.11 | 587.13 | 391.06 | 185.97 | Upgrade |
Net Income Growth | -17.82% | 21.76% | 4.25% | 50.14% | 110.29% | 15.90% | Upgrade |
Shares Outstanding (Basic) | 941 | 950 | 947 | 950 | 917 | 637 | Upgrade |
Shares Outstanding (Diluted) | 941 | 950 | 947 | 950 | 919 | 637 | Upgrade |
Shares Change (YoY) | -1.28% | 0.28% | -0.33% | 3.38% | 44.25% | 0.21% | Upgrade |
EPS (Basic) | 0.70 | 0.78 | 0.65 | 0.62 | 0.43 | 0.29 | Upgrade |
EPS (Diluted) | 0.70 | 0.78 | 0.65 | 0.62 | 0.43 | 0.29 | Upgrade |
EPS Growth | -16.75% | 21.42% | 4.60% | 45.23% | 45.78% | 15.66% | Upgrade |
Free Cash Flow | -492.47 | -198.92 | 301.74 | 145.58 | 82.06 | 154.66 | Upgrade |
Free Cash Flow Per Share | -0.52 | -0.21 | 0.32 | 0.15 | 0.09 | 0.24 | Upgrade |
Dividend Per Share | 0.269 | 0.385 | 0.154 | 0.062 | 0.043 | - | Upgrade |
Dividend Growth | - | 150.06% | 149.27% | 43.16% | - | - | Upgrade |
Gross Margin | 47.76% | 49.08% | 51.48% | 52.13% | 46.05% | 48.82% | Upgrade |
Operating Margin | 28.29% | 29.88% | 27.21% | 24.41% | 21.82% | 21.58% | Upgrade |
Profit Margin | 26.11% | 28.08% | 26.28% | 24.41% | 19.83% | 17.71% | Upgrade |
Free Cash Flow Margin | -19.66% | -7.49% | 12.96% | 6.05% | 4.16% | 14.73% | Upgrade |
EBITDA | 828 | 913.93 | 770.71 | 704.63 | 538.01 | 273.96 | Upgrade |
EBITDA Margin | 33.05% | 34.43% | 33.10% | 29.30% | 27.29% | 26.09% | Upgrade |
D&A For EBITDA | 119.34 | 120.8 | 137.02 | 117.62 | 107.82 | 47.37 | Upgrade |
EBIT | 708.66 | 793.13 | 633.7 | 587.01 | 430.2 | 226.59 | Upgrade |
EBIT Margin | 28.29% | 29.88% | 27.21% | 24.41% | 21.82% | 21.58% | Upgrade |
Effective Tax Rate | 12.90% | 12.63% | 11.14% | 11.01% | 14.51% | 15.89% | Upgrade |
Revenue as Reported | 2,505 | 2,655 | 2,329 | 2,405 | 1,972 | 1,050 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.